AI News NQ Analysis

[HoKang Biotech] February 2026 Monthly Revenue: NT$0.48 Billion (YoY +20.9%)

NQ Score 67/100
N1 Content Completeness 7

AI Summary (NQ-processed)

HoKang Biotech (1783) announced its February 2026 revenue of NT$0.48 billion, achieving a year-on-year growth of 20.9%. The company, part of the biotechnology and medical industry, specializes in collagen and hyaluronic acid medical materials. This revenue increase reflects strong demand in the medical aesthetics and orthopedics markets.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What was HoKang Biotech's total revenue for February 2026?
A: HoKang Biotech's total revenue for February 2026 was NT$47,965 thousand, which is equivalent to NT$0.48 billion.
Q: How did HoKang Biotech's revenue in February 2026 compare to the previous year?
A: HoKang Biotech's revenue in February 2026 experienced a year-over-year increase of 20.9% compared to the previous year.
Q: What is the company code for HoKang Biotech?
A: The company code for HoKang Biotech is 1783.
Q: In which industry does HoKang Biotech operate?
A: HoKang Biotech operates within the Biotechnology and Medical Data industry.
Q: What was the exact revenue figure in thousands for HoKang Biotech in February 2026?
A: The exact revenue figure for HoKang Biotech in February 2026 was NT$47,965 thousand.